{ "data": { "asOf": "2026-10-30T22:26:30.887Z", "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "byRegistry": { "clinicaltrials_gov": 1 }, "canonicalTrial": { "canonicalId": "NCT07837973", "title": "Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss", "scientificTitle": "A Double-Blind, Randomized, Multi-Center, Dose-Ranging, Phase 2 Study of the Efficacy and Safety of ALV-100 Versus Placebo for Maintenance of Weight Loss in Patients Previously Treated With Incretin-Based Therapies", "status": "recruiting", "studyType": "interventional", "phase": [ "PHASE2" ], "conditions": [ "Overweight , Obesity", "Adults" ], "interventions": [ { "name": "ALV-100", "type": "DRUG", "description": "Experimental drug" }, { "name": "Placebo", "type": "DRUG", "description": "Volume matched placebo" } ], "sponsor": { "name": "Alveus Therapeutics, Inc.", "type": "INDUSTRY" }, "locations": [ { "city": "Birmingham", "country": "United States", "facility": "University of Alabama - Birmingham" }, { "city": "Sun City", "country": "United States", "facility": "DM Clinical Research" }, { "city": "Tempe", "country": "United States", "facility": "AMR Clinical" }, { "city": "Oceanside", "country": "United States", "facility": "Profound Research" }, { "city": "Bradenton", "country": "United States", "facility": "DM Clinical Research" }, { "city": "Doral", "country": "United States", "facility": "DM Clinical Research" }, { "city": "Orlando", "country": "United States", "facility": "Clinical Neuroscience Solutions" }, { "city": "Woodstock", "country": "United States", "facility": "North Georgia Clinical Research" }, { "city": "Champaign", "country": "United States", "facility": "Christie Clinic" }, { "city": "Gretna", "country": "United States", "facility": "BRCR Global Louisiana" }, { "city": "Farmington Hills", "country": "United States", "facility": "Profound Research" }, { "city": "New York", "country": "United States", "facility": "ALSA Research-Manhattan" }, { "city": "Wilmington", "country": "United States", "facility": "TMA Headlands" }, { "city": "Oklahoma City", "country": "United States", "facility": "Lynn Health Science Institute" }, { "city": "Nashville", "country": "United States", "facility": "AMR Clinical" }, { "city": "Irving", "country": "United States", "facility": "DM Clinical Research" }, { "city": "San Antonio", "country": "United States", "facility": "DM Clinical Research - Dominion Family Healthcare" }, { "city": "San Antonio", "country": "United States", "facility": "Tekton Research" }, { "city": "Tomball", "country": "United States", "facility": "DM Clinical Research" }, { "city": "South Jordan", "country": "United States", "facility": "AMR Clinical" } ], "outcomes": { "other": [], "primary": [ "Dose response of ALV-100 as assessed by maintenance of weight loss" ], "secondary": [ "Assess the safety and tolerability of ALV-100", "Efficacy of ALV-100 compared to placebo as assessed by maintenance of weight loss", "Change from baseline in glycemic control parameters", "Change from baseline in lipid parameters", "Change from baseline in vital signs", "Immunogenicity of ALV-100", "Efficacy of ALV-100 versus placebo on subjective control of eating, food cravings, and mood-related eating behaviors as assessed by the Control of Eating Questionnaire (CoEQ)", "Effect of ALV-100 vs. placebo on food noise as assessed by the Food Noise Questionnaire (FNQ)" ] }, "eligibility": { "sex": "ALL", "criteria": "Key inclusion criteria\n\n1. Adult male and female participants, aged ≥18 to ≤75\n2. BMI ≥23 kg/m2 at screening.\n3. Has been treated with incretin-based therapy for weight management at a stable dose for at least 3 continuous months prior to screening.\n4. Tolerating incretin-based therapy at the discretion of the investigator\n5. WL of at least 10% while on incretin-based therapy and with stable BW for at least 3 months prior to screening.\n6. Willing to maintain their current general diet and physical activity regimen throughout the study.\n\nKey exclusion criteria\n\n1. Lifetime history of Type 1 or Type 2 diabetes\n2. Prior obesity treatment with surgery or a weight loss device.\n3. Obesity caused by known endocrinologic disorders or by known congenital or acquired hypothalamic disease or monogenetic or syndromic forms of obesity.\n4. Current or history of (within 3 months prior to screening) treatment with medications that may cause significant weight gain.\n5. Family or personal history of MTC or MEN 2\n6. Presence or history of malignant neoplasms within the past 5 years prior to screening", "maximumAge": "75 Years", "minimumAge": "18 Years", "healthyVolunteers": false }, "enrollment": { "type": "ESTIMATED", "count": 220 }, "startDate": "2026-08-10", "completionDate": "2027-08-24", "lastUpdated": "2026-10-26T00:00:00.000Z", "firstPosted": "2026-09-24T00:00:00.000Z", "resultsAvailable": false, "sourceRegistries": [ "clinicaltrials_gov" ], "sourceUrls": [ "https://clinicaltrials.gov/study/NCT07837973" ] }, "identifiers": [ { "idType": "nct", "idValue": "NCT07837973", "declaredBy": "clinicaltrials_gov" } ], "sourceRecords": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT07837973", "sourceUrl": "https://clinicaltrials.gov/study/NCT07837973", "sourceStatus": "RECRUITING", "retrievedAt": "2026-10-28T04:32:38.877Z", "payloadSha256": "92da93abc737c76f7c92e640c5769ded1b0d5659a2bb596f220917ba1909f8b8", "piiRedacted": true } ], "citation": { "canonicalId": "NCT07837973", "sources": [ { "registry": "clinicaltrials_gov", "registryName": "ClinicalTrials.gov", "license": "public-domain", "sourceId": "NCT07837973", "verifyAt": "https://clinicaltrials.gov/study/NCT07837973", "retrievedAt": "2026-10-28T04:32:38.877Z", "payloadSha256": "92da93abc737c76f7c92e640c5769ded1b0d5659a2bb596f220917ba1909f8b8", "text": "ClinicalTrials.gov, record NCT07837973 (https://clinicaltrials.gov/study/NCT07837973), retrieved 2026-10-28, licence: public-domain." } ], "crossRegistry": false, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "text": "Trial NCT07837973, registered in ClinicalTrials.gov, retrieved 2026-10-28. Verify at the source URLs listed; each retrieval is checksummed.", "note": "Only one registry is known to hold this trial. Absence from the others is not evidence it was not registered there." }, "provenanceNote": "Personal contact fields (names, emails, phone numbers, addresses) are stripped from every stored payload. No participant-level data is collected or served." }, "_meta": { "api": "The Last Economy Wire: World Trials API", "version": "1.0", "schemaVersion": "1", "correlationId": "req_FcQ82R-UuZqs", "generatedAt": "2026-10-30T22:26:30.887Z", "documentation": "https://negativeresistance.com/embed", "license": "Free for any use. Attribution appreciated.", "degraded": false, "provenance": { "sources": [ "clinicaltrials_gov" ], "attribution": { "clinicaltrials_gov": "ClinicalTrials.gov: licence: public-domain, https://clinicaltrials.gov/data-api/api-docs" }, "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only", "limitations": [], "provenanceEndpoint": "/api/v1/sources" }, "freshness": { "newestEvidenceAt": null, "lastSyncedAt": { "clinicaltrials_gov": "2026-10-28T04:33:30.663Z" }, "degradedSources": [], "worldwide": false, "maxAgeHours": 65.9, "fromCache": false }, "links": { "discovery": "https://negativeresistance.com/api/v1", "openapi": "https://negativeresistance.com/api/v1/openapi.json", "mcp": "https://negativeresistance.com/api/v1/mcp", "agentCard": "https://negativeresistance.com/.well-known/agent.json", "aiPlugin": "https://negativeresistance.com/.well-known/ai-plugin.json", "sdk": "https://negativeresistance.com/api/v1/sdk", "status": "https://negativeresistance.com/api/v1/status", "provenance": "https://negativeresistance.com/api/v1/sources", "contract": "https://negativeresistance.com/api/v1/contract", "curriculum": "https://negativeresistance.com/api/v1/curriculum", "graph": "https://negativeresistance.com/api/v1/graph", "openQuestions": "https://negativeresistance.com/api/v1/open-questions", "scoreboard": "https://negativeresistance.com/api/v1/scoreboard", "findings": "https://negativeresistance.com/api/v1/findings", "claims": "https://negativeresistance.com/api/v1/claims", "threads": "https://negativeresistance.com/api/v1/threads", "assignment": "https://negativeresistance.com/api/v1/assignment", "changes": "https://negativeresistance.com/api/v1/changes", "hello": "https://negativeresistance.com/api/v1/hello", "errors": "https://negativeresistance.com/api/v1/errors", "webhooks": "https://negativeresistance.com/api/v1/webhooks", "a2a": "https://negativeresistance.com/api/v1/a2a", "deadEnds": "https://negativeresistance.com/api/v1/dead-ends", "decompositions": "https://negativeresistance.com/api/v1/decompositions", "rungs": "https://negativeresistance.com/api/v1/rungs", "methods": "https://negativeresistance.com/api/v1/methods", "reality": "https://negativeresistance.com/api/v1/reality", "council": "https://negativeresistance.com/api/v1/council", "calibration": "https://negativeresistance.com/api/v1/calibration", "freshness": "https://negativeresistance.com/api/v1/freshness", "mission": "https://negativeresistance.com/api/v1/mission", "twin": "https://negativeresistance.com/api/v1/twin", "twinExperiment": "https://negativeresistance.com/api/v1/twin/experiment", "betaCell": "https://negativeresistance.com/api/v1/twin/beta-cell", "patientModel": "https://negativeresistance.com/api/v1/twin/patient-model", "agentCardCanonical": "https://negativeresistance.com/.well-known/agent-card.json", "collaborate": "https://negativeresistance.com/collaborate", "manifesto": "https://negativeresistance.com/about", "documentation": "https://negativeresistance.com/embed", "connect": "https://negativeresistance.com/connect", "llmsTxt": "https://negativeresistance.com/llms.txt", "llmsFullTxt": "https://negativeresistance.com/llms-full.txt" }, "disclaimer": "Research data from public registries and literature; not medical advice." } }